Get the Stockscreener App
2.99
0.99%
-0.03
Pre-market:
3.06
0.07
+2.34%
Painreform Ltd Stock (PRFX) Forecast
The Painreform Ltd (PRFX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.8575, representing a -71.32% decrease from the current price of $2.99. The highest analyst price target is $0.6809, and the lowest is $1.034.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PRFX Price Target
Average 1.367
(-54.28% Downside)
Is Painreform Ltd (PRFX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.33 | Neutral |
| STOCH(9,6) | 25.10 | Neutral |
| STOCHRSI(14) | 47.74 | Neutral |
| MACD(12,26) | -0.164 | Sell |
| ADX(14) | 51.49 | Buy |
| William %R | -70.71 | Neutral |
| CCI(14) | -15.79 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.095
Sell
|
3.1371
Sell
|
| MA20 |
3.8912
Sell
|
3.3175
Sell
|
| MA50 |
3.2923
Sell
|
3.4506
Sell
|
| MA100 |
3.2611
Sell
|
5.237
Sell
|
| MA200 |
9.4492
Sell
|
14.77
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PRFX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on PRFX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.33 indicates that PRFX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.1 indicates that PRFX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 47.74 indicates that PRFX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 51.49 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -15.79 indicates that PRFX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PRFX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Painreform Ltd financial reports and earnings history, Painreform Ltd (PRFX) stock could reach $5.1542 by 2030, $2.1842 by 2040 and $22.22 by 2050. See the projected annual prices until 2050 of the Painreform Ltd stock below:
- Painreform Ltd (PRFX) is expected to reach an average price of $6.3478 in 2035, with a high prediction of $6.4211 and a low estimate of $6.3281. This indicates an $112.30% rise from the last recorded price of $2.99.
- Painreform Ltd (PRFX) stock is projected to chart a bullish course in 2040, with an average price target of $2.5642, representing an $-14.24% surge from its current level. The forecast ranges from a conservative $2.0068 to a sky-high $2.1842.
- Our analysts predict Painreform Ltd (PRFX) to jump 618.30% by 2045, soaring from $21.78 to an average price of $21.48, potentially reaching $22.20. While $21.78 is the low estimate, the potential upside is significant.
- Painreform Ltd (PRFX) stock is expected to climb by 2050, reaching an average of $22.04, a $637.18% jump from its current level. However, a wide range of estimates exists, with high and low targets of $22.22 and $22.06, respectively, highlighting the market's uncertainty.
Painreform Ltd Stock (PRFX) Year by Year Forecast
Painreform Ltd Stock (PRFX) Price Forecast for 2025
Painreform Ltd Stock (PRFX) is expected to reach an average price of $1.367 in 2025, with a high prediction of $2.069 and a low estimate of $0.6651. This indicates an -54.28% fall from the last recorded price of $2.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $0.8209 | $1.034 | $0.6809 | -72.55% |
| March, 2025 | $0.96 | $1.0054 | $0.8177 | -67.89% |
| April, 2025 | $1.0914 | $0.9546 | $1.4977 | -63.50% |
| May, 2025 | $0.8105 | $0.7083 | $0.636 | -72.89% |
| June, 2025 | $0.6947 | $0.6651 | $0.6297 | -76.77% |
| July, 2025 | $1.0711 | $0.9319 | $0.8788 | -64.18% |
| August, 2025 | $1.5802 | $1.1533 | $1.4002 | -47.15% |
| September, 2025 | $1.7093 | $1.7725 | $1.6393 | -42.83% |
| October, 2025 | $2.1107 | $1.9733 | $1.9607 | -29.41% |
| November, 2025 | $2.0798 | $2.0798 | $2.013 | -30.44% |
| December, 2025 | $1.9412 | $2.1147 | $2.069 | -35.08% |
Painreform Ltd Stock (PRFX) Price Forecast for 2026
The predicted value for Painreform Ltd (PRFX) in 2026 is set at an average of $1.8074. Estimates vary from a peak of $1.9603 to a trough of $1.6545, indicating an -39.55% surge from the present price of $2.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.8104 | $1.8158 | $1.7681 | -39.45% |
| February, 2026 | $2.0694 | $1.7878 | $1.8495 | -30.79% |
| March, 2026 | $1.9388 | $2.0586 | $1.9603 | -35.16% |
| April, 2026 | $1.802 | $1.85 | $1.8709 | -39.73% |
| May, 2026 | $1.9464 | $1.8323 | $1.8411 | -34.90% |
| June, 2026 | $1.8082 | $1.8681 | $1.8914 | -39.52% |
| July, 2026 | $1.8497 | $1.8369 | $1.8528 | -38.14% |
| August, 2026 | $1.7962 | $1.8438 | $1.7763 | -39.93% |
| September, 2026 | $1.8102 | $1.8411 | $1.7956 | -39.46% |
| October, 2026 | $1.8493 | $1.8335 | $1.8273 | -38.15% |
| November, 2026 | $1.8057 | $1.8204 | $1.6661 | -39.61% |
| December, 2026 | $1.6298 | $1.6545 | $1.7108 | -45.49% |
Painreform Ltd Stock (PRFX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Painreform Ltd (PRFX) is $12.63, with a high forecast of $24.74 and a low forecast of $0.5246. This indicates an +322.50% increase from the last price of $2.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4319 | $1.4885 | $1.5821 | -52.11% |
| February, 2027 | $1.4621 | $1.4558 | $1.4142 | -51.10% |
| March, 2027 | $1.2895 | $1.3272 | $1.2372 | -56.87% |
| April, 2027 | $1.2112 | $1.2463 | $1.2718 | -59.49% |
| May, 2027 | $1.2923 | $1.3154 | $1.2893 | -56.78% |
| June, 2027 | $6.4309 | $1.258 | $24.74 | +115.08% |
| July, 2027 | $5.0118 | $4.7918 | $9.8985 | +67.62% |
| August, 2027 | $3.2426 | $2.6249 | $5.9695 | +8.45% |
| September, 2027 | $2.0412 | $1.7312 | $3.2904 | -31.73% |
| October, 2027 | $0.902 | $0.8421 | $2.0789 | -69.83% |
| November, 2027 | $0.833 | $0.5246 | $1.6853 | -72.14% |
| December, 2027 | $1.3916 | $0.5882 | $1.6506 | -53.46% |
Painreform Ltd Stock (PRFX) Price Forecast for 2028
In 2028, Painreform Ltd (PRFX) is projected to reach an average price of $2.2506, with a high projection of $4.4667 and a low estimate of $0.0346. This indicates an -24.73% fall from the last price of $2.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.3125 | $1.1893 | $2.187 | -56.11% |
| February, 2028 | $0.8533 | $0.8033 | $1.4802 | -71.46% |
| March, 2028 | $1.3288 | $0.8011 | $1.4519 | -55.56% |
| April, 2028 | $0.9128 | $0.8551 | $1.3217 | -69.47% |
| May, 2028 | $0.1049 | $0.0346 | $1.6782 | -96.49% |
| June, 2028 | $4.4793 | $0.1113 | $3.8793 | +49.81% |
| July, 2028 | $4.3448 | $4.4284 | $4.1176 | +45.31% |
| August, 2028 | $3.9564 | $4.2604 | $4.4667 | +32.32% |
| September, 2028 | $3.7186 | $4.1085 | $4.0795 | +24.37% |
| October, 2028 | $4.0269 | $4.2432 | $4.0323 | +34.68% |
| November, 2028 | $1.8097 | $2.6397 | $3.506 | -39.48% |
| December, 2028 | $4.0579 | $3.1487 | $3.2679 | +35.72% |
Painreform Ltd Stock (PRFX) Price Forecast for 2029
The 2029 price forecast for Painreform Ltd Stock (PRFX) is $4.4365 on average, with a high prediction of $5.206 and a low estimate of $3.667. This represents an +48.38% increase from the previous price of $2.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.6907 | $3.667 | $4.4507 | +56.88% |
| February, 2029 | $5.339 | $4.8453 | $5.149 | +78.56% |
| March, 2029 | $4.7272 | $4.9181 | $4.5427 | +58.10% |
| April, 2029 | $4.8155 | $4.8009 | $4.6063 | +61.05% |
| May, 2029 | $4.667 | $4.6791 | $4.3283 | +56.09% |
| June, 2029 | $4.3165 | $4.3265 | $4.3928 | +44.36% |
| July, 2029 | $4.3048 | $4.2302 | $4.2211 | +43.97% |
| August, 2029 | $4.5676 | $4.3393 | $4.3376 | +52.76% |
| September, 2029 | $4.8258 | $4.5521 | $4.1967 | +61.40% |
| October, 2029 | $5.0086 | $5.0204 | $4.9386 | +67.51% |
| November, 2029 | $5.2869 | $5.2195 | $5.0223 | +76.82% |
| December, 2029 | $5.1901 | $5.2551 | $5.206 | +73.58% |
Painreform Ltd Stock (PRFX) Price Forecast for 2030
Painreform Ltd Stock (PRFX) is expected to reach an average price of $4.6142 in 2030, with a high forecast of $5.1542 and a low forecast of $4.0742. This signifies an +54.32% surge from the last price of $2.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.1379 | $5.2013 | $5.1542 | +71.84% |
| February, 2030 | $4.8112 | $4.8162 | $4.8125 | +60.91% |
| March, 2030 | $4.9154 | $4.7327 | $4.7087 | +64.39% |
| April, 2030 | $4.8347 | $4.979 | $4.852 | +61.70% |
| May, 2030 | $4.5454 | $4.7013 | $4.72 | +52.02% |
| June, 2030 | $4.5937 | $4.5518 | $4.4791 | +53.64% |
| July, 2030 | $4.4165 | $4.4764 | $4.5528 | +47.71% |
| August, 2030 | $4.3322 | $4.392 | $4.4256 | +44.89% |
| September, 2030 | $4.283 | $4.333 | $4.2605 | +43.24% |
| October, 2030 | $4.2438 | $4.2412 | $4.2176 | +41.93% |
| November, 2030 | $4.169 | $4.1583 | $4.1527 | +39.43% |
| December, 2030 | $4.1117 | $4.0742 | $4.1166 | +37.51% |
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):